loader2
Partner With Us NRI

Company details

783.00
802.00
319.00
1,024.40
6M Return 33.25%
1Y Return 120.79%
Mkt Cap.(Cr) 764.17
Volume 1,800
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 1,800

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 68.61 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 2,805.20 26,355.35
LAST 3M 41,700.80 -10,395.59
LAST 6M 127,269.18 -151,588.49
LAST 12M 214,610.04 -219,403.16
  • Announcement
  • Corporate action
  • No Data Found

Date Action Type Ratio
No data found

Information

  • About Company
  • Company Info
  • Listing Info
30.89
66.71%
96.0535
15.68%
11.65%
Description
  • Beta Drugs Limited was incorporated as a private limited company with the name `Beta Drugs Private limited` at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to public limited company and the name of the company was changed to `Beta Drugs Limited` on August 11, 2017 Beta Drugs is a part of Adley Group. Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India. The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014. The company is primarily engaged in the manufacturing of oncology products. The Company`s products range from anti-cancer tablets, capsules, injections and lyophilized injections. The Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease. As on March 31, 2017, the company had a portfolio of over 50 products catering to various oncology diseases including breast, brain, bone, lung, mouth, head & neck, prostate, haematology, cervics, oeaophagus etc.

Read More

No Data Found

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1600
BSE Code : 535022
NSE Code : BETA
Book Closure Date (Month) : Sep
BSE Group :
ISIN : INE351Y01019

ICICIdirect Beta Drugs Ltd FAQ

You can buy Beta Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Beta Drugs Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Aug 11, 2022 03:46 PM the closing price of Beta Drugs Ltd was ₹ 794.85.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Aug 11, 2022 03:46 PM, the market cap of Beta Drugs Ltd stood at ₹ 764.17.
The latest PE ratio of Beta Drugs Ltd as of Aug 11, 2022 03:46 PM is 30.89
The latest PB ratio of Beta Drugs Ltd as of Aug 11, 2022 03:46 PM is 0.12
The 52-week high of Beta Drugs Ltd is ₹ 1,024.40 while the 52-week low is ₹ 319.00 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE